Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chemotherapy
100%
Response to Neoadjuvant Chemotherapy
100%
Methylenetetrahydrofolate Reductase (MTHFR)
100%
Barrett's Carcinoma
100%
Multidrug Resistance Protein 1 (MDR1)
100%
Locally Advanced
75%
Caldesmon
75%
Gene Expression
50%
Expression Level
50%
5-fluorouracil (5-FU)
50%
Human Epidermal Growth Factor Receptor 2 (HER2)
50%
Barrett's Adenocarcinoma
50%
ERCC4
50%
Quantitative PCR
25%
Cisplatin
25%
MRNA Level
25%
Expression Profile
25%
Relevant Genes
25%
Cancer Patients
25%
Tumor Tissue
25%
Tumor Biopsy
25%
Survival Benefit
25%
Paclitaxel
25%
After Surgery
25%
Gene Expression Pattern
25%
Dihydropyrimidine Dehydrogenase
25%
Neoadjuvant Chemotherapy
25%
Taxanes
25%
Response to Chemotherapy
25%
Adenocarcinoma
25%
Esophageal Adenocarcinoma
25%
Formalin-fixed
25%
Tumor Area
25%
Thymidine Phosphorylase
25%
Esophageal Tumor
25%
Paraffin Embedding
25%
Intratumoral Heterogeneity
25%
Esophagectomy
25%
ERCC1
25%
ELF3
25%
MAP7
25%
GADD45
25%
Thymidylate
25%
Metabolism-related Genes
25%
2-cycles
25%
Drug Resistance Gene
25%
Carcinoma Esophagus
25%
Biopsy Material
25%
Surgically Resected Specimen
25%
Genetic Expression Profiles
25%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Caldesmon
75%
Expression Level
75%
Fluorouracil
50%
Metabolic Pathway
25%
RNA
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Esophagus
25%
ERCC1
25%
Cisplatin
25%
Multidrug Resistance
25%
Dihydropyrimidine Dehydrogenase
25%
Methylenetetrahydrofolate Reductase
25%
Thymidine Monophosphate
25%
Thymidine Phosphorylase
25%
Messenger RNA
25%